
Novax continues to invest in building new platforms with the ambition ofdeveloping future cornerstones of the Axel Johnson group. As part of this work, Fanny Leksell will join as Director on 11 January 2027. She brings more than 12 years of experience in investments, active ownership and business development, most recently at Priveq.
Over the past few years, Novax has established several platforms withinfood, security and health, including Bond Health Group, Ingå Group, Latend, RCOGroup, Apohem and Personalkollen. Building on this foundation, Novax continuesto identify companies with the potential to form the basis of new platforms.Fanny Leksell will play a key role in driving this work forward.
“We have built a strong foundation at Novax and see exciting opportunitiesto develop new platforms in the years ahead. Identifying the right companies, building strong relationships and developing businesses over time is at the heart of what we do. Fanny brings extensive investment experience, a strong network and a proven ability to identify opportunities and help companies grow. We are very pleased to welcome her to the team,” says Jonas Hedman, CEO of Novax.
“What drew me to Novax is the opportunity to build and develop companieswith an owner who has the patience to think in decades, combined with a strongambition to grow. I look forward to meeting ambitious business leaders, exploring new opportunities and contributing to the development of Novax’s future platforms,” says Fanny Leksell.
For more information, please contact:
Jonas Hedman, CEO, Novax, Jonas.Hedman@novax.se